Voyager Therapeutics, Inc. (VYGR)
3.51
+0.08
(+2.33%)
USD |
NASDAQ |
Sep 02, 15:02
Voyager Therapeutics Total Liabilities (Quarterly) : 43.38M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 43.38M |
| March 31, 2026 | 45.66M |
| December 31, 2025 | 56.20M |
| September 30, 2025 | 68.49M |
| June 30, 2025 | 78.16M |
| March 31, 2025 | 80.54M |
| December 31, 2024 | 93.29M |
| September 30, 2024 | 95.73M |
| June 30, 2024 | 100.81M |
| March 31, 2024 | 128.71M |
| December 31, 2023 | 114.96M |
| September 30, 2023 | 118.43M |
| June 30, 2023 | 116.51M |
| March 31, 2023 | 119.33M |
| December 31, 2022 | 100.34M |
| September 30, 2022 | 102.66M |
| June 30, 2022 | 128.55M |
| March 31, 2022 | 148.25M |
| December 31, 2021 | 98.80M |
| September 30, 2021 | 97.35M |
| June 30, 2021 | 98.19M |
| March 31, 2021 | 101.51M |
| December 31, 2020 | 107.26M |
| Date | Value |
|---|---|
| September 30, 2020 | 103.52M |
| June 30, 2020 | 220.57M |
| March 31, 2020 | 242.85M |
| December 31, 2019 | 255.25M |
| September 30, 2019 | 268.06M |
| June 30, 2019 | 270.19M |
| March 31, 2019 | 310.66M |
| December 31, 2018 | 130.58M |
| September 30, 2018 | 131.48M |
| June 30, 2018 | 132.69M |
| March 31, 2018 | 136.73M |
| December 31, 2017 | 50.43M |
| September 30, 2017 | 55.71M |
| June 30, 2017 | 53.12M |
| March 31, 2017 | 52.39M |
| December 31, 2016 | 53.64M |
| September 30, 2016 | 52.86M |
| June 30, 2016 | 54.11M |
| March 31, 2016 | 56.38M |
| December 31, 2015 | 60.38M |
| September 30, 2015 | 64.72M |
| June 30, 2015 | 69.05M |
| March 31, 2015 | 72.46M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 197.75M |
| Shareholders Equity (Quarterly) | 154.38M |
| Debt to Equity Ratio | 0.211 |
| Current Ratio | 7.505 |
| Net Debt Paydown Yield | 0.88% |